4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001359820-12-000002
CEO bought 10,000 shares at an average $0.52 ($5,155)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/primary_doc.xml…